Figure 1. Domains of Gene Expression in the Somites
A schematic diagram of a transverse section through the neural tube and differentiated somites is shown. Domains of expression of various regulatory genes are indicated. ec, surface ectoderm; lb, limb bud; der, dermomyotome; my, myotome; scl, sclerotome; nt, neural tube; no, notochord. that migrate from the dermomyotome to the limb bud c-Met, which binds the migratory peptide growth factor, are committed to a myogenic fate, but they do not exscatter factor (Bladt et al., 1995) . The absence of c-Met press the myogenic bHLH genes until they reach their expression in splotch mice suggests that c-met is a destination, at which time these regulatory genes are likely target gene for Pax-3 and that the lack of c-Met switched on and myogenesis ensues. How these migrasignaling accounts for the inability of splotch myoblasts tory cells maintain their commitment to a myogenic fate to migrate (Yang et al., 1996) . in the absence of myogenic bHLH gene expression has
In the paper from Buckingham's group (Tajbakhsh et  been a mystery. al., 1997), Pax-3 and Myf-5 mutations were combined by A Pathway of Myogenic bHLH Genes intercrossing the two mutant lines of mice. Remarkably, The phenotypes (or lack thereof) of mice lacking the mice lacking both genes developed virtually no skeletal myogenic bHLH genes have provided a framework for muscle in the trunk and failed to express MyoD in this thinking about the roles of these genes in specification region of the embryo. Since MyoD is expressed in trunk and differentiation of the skeletal muscle lineage. Mice muscle precursors of Myf-5-null embryos, its failure to lacking either MyoD or Myf-5 form skeletal muscle that be expressed in Myf-5/Pax-3 double mutants reveals an is essentially normal, whereas mice lacking both genes essential role for Pax-3 as a regulator of MyoD expresare devoid of skeletal muscle cells and show no expression. Thus, in addition to its role in regulating migration sion of molecular markers of the skeletal muscle lineage, of limb muscle precursors, Pax-3 also appears to act supporting the notion that these genes act at an early like Myf-5 to control MyoD expression and specification step in the lineage to specify myoblast identity (Rudnicki of trunk muscles. Myf-5 double mutants and are therefore dependent on and myoblasts are properly specified and positioned, the compensatory pathways controlled by these myobut there is a block in differentiation. Myogenin therefore genic bHLH genes, MyoD expression in the head muscle appears to lie in a genetic pathway downstream of MyoD lineage must be Pax-3-independent. Consistent with and Myf-5 and to have a unique role in activating the this notion, neither Pax-3 nor Pax-7 is expressed in head program for muscle cell differentiation (Molkentin and muscle precursors. Olson, 1996) .
An important question that arises from these results
Necessity of Pax-3 for Muscle Development
is whether MyoD expression is completely independent Several members of the Pax family of homeobox genes of Myf-5 or whether there may also be a Myf-5-mediated are expressed in distinct domains within developing sopathway for MyoD activation. On this issue, there is mites. Pax-3 and Pax-7 are expressed in the paraxial disagreement. Tajbakhsh et al. (1997) show that MyoD mesoderm prior to somitogenesis and in the dorsal expression is delayed in most but not all of the trunk halves of epithelial somites before becoming restricted somites of Myf-5 mutant embryos, which they interpret to the ventrolateral and dorsomedial domains, respecto indicate that the initial activation of MyoD is depentively, of the dermomyotome (Goulding et al., 1991;  dent on Myf-5 and that Pax-3 regulates MyoD expresJostes et al., 1991). Both Pax-3 and Pax-7 are excluded sion later. This conclusion is supported by their observafrom the myotome. Pax-3 is also expressed in the migration that Myf-5 and MyoD are expressed in the same tory population of myogenic precursors that enters the myotomal muscle cells of normal embryos. However, limb buds from the dermomyotome and is down-reguthese conclusions differ from those of previous studies lated as these cells begin to differentiate and express which concluded that MyoD was activated on time in MyoD and Myf-5. In addition to their expression in paraMyf-5 mutant embryos and that the expression of MyoD xial mesoderm, Pax-3 and Pax-7 are expressed at high and Myf-5 was mutually exclusive at the cellular level levels in the dorsal neural tube.
in vivo and in embryonic stem cells in vitro (Braun and The first indication of a role for Pax-3 in muscle devel- Arnold, 1996) . This discrepancy may be reconciled if opment came from the phenotype of the splotch mouse MyoD expression is dependent on Myf-5 in some muscle mutant, which lacks a functional Pax-3 gene, and is cell types and independent in others. devoid of limb muscles (Bober et al., 1994) . Muscles of How important is the Pax-3-dependent pathway for the back and body wall are unaffected in splotch mice, MyoD expression during skeletal muscle development? consistent with their origin from a separate muscle linThe simplest interpretation is that this pathway can be eage from the limb musculature. If the lateral halves of almost entirely compensated for by Myf-5. That MyoD somites derived from splotch mice are transplanted into is expressed in the myotomal muscle lineage of Pax-3 the limb buds of chick embryos, the mutant mouse myomutant mice indicates that there must be a Pax-3-indeblasts are able to differentiate (Daston et al., 1996) . This pendent pathway for MyoD gene activation and Myf-5 suggests that the muscle deficiency in splotch mice would seem to be the likely regulator of MyoD in this results from a failure of muscle precursors to invade the situation. Conversely, in the Myf-5-mutant mouse, the limb, rather than an inability of myoblasts to differentiPax-3-dependent pathway can apparently support norate. The limb muscle phenotype of splotch mice is similar to that of mice lacking the tyrosine kinase receptor mal muscle development. It is unlikely that Pax-7 can substitute for Pax-3 to support MyoD expression, since neurogenic program is extinguished in neural cells that are converted to a myogenic fate also has not yet been Pax-7 continues to be expressed in Pax-3/Myf-5 double mutants in which MyoD fails to be expressed. The examined. Surprisingly, Pax-3 was unable to induce myogenesis phenotype of Pax-7/Myf-5 mutant mice will be of interest in this regard. It is also important to keep in mind that in the 10T1/2 mouse fibroblast-like cell line, which is readily converted to muscle by MyoD and was originally Pax-3 and MyoD are expressed in mutually exclusive patterns in the somite and lateral muscle lineage, sugused to characterize the myogenic activity of MyoD. In fact, forced expression of Pax-3 in 10T1/2 cells blocks gesting that Pax-3 is likely to be involved in activation, but not in maintenance of MyoD expression. their ability to induce muscle genes in response to MyoD and in the C2 muscle cell line, Pax-3 blocks differentiaSufficiency of Pax-3 for Myogenesis The study from Tajbakhsh et al. (1997) indicates that tion (Epstein et al., 1995) . Thus, the factors required for muscle gene activation by MyoD must be distinct from Pax-3 is necessary for normal myogenesis in vivo and that it regulates (directly or indirectly) MyoD expression; those required by Pax-3. Moreover, in a subset of alveolar rhabdomyosarcomas, chromosomal translocation but is Pax-3 sufficient to activate the myogenic program? The answer seems to be yes, sometimes. In the results in fusion of the amino-terminal DNA binding domain of Pax-3 to the C-terminal transcription activation study by Maroto et al. (1997) , Pax-3 was expressed ectopically in a variety of nonmuscle cell types and was domain of the forkhead transcription factor FKHR, resulting in the creation of a novel transcription factor that found, under some conditions, to activate MyoD expression and myogenic differentiation.
prevents myogenesis (Barr et al., 1993) . Cell Background Determines Myogenic Potential An initial clue that Pax-3 (and possibly Pax-7) might be an activator of MyoD expression came from experi-
The ability of Pax-3 to activate myogenesis in some cell types and inhibit it in others dramatizes the importance ments in which explants of chick paraxial mesoderm were assayed for their ability to activate myogenesis in of cell background in dictating transcriptional responsiveness of muscle genes. The simplest explanation for response to Wnts, Shh, and ectoderm. Activation of MyoD expression under these conditions was preceded this specificity in responsiveness is the existence of unique combinations of positive and negative regulatory by expression of Pax-3 and Pax-7, as well as Myf-5. Using a retroviral expression system, Maroto et al. (1997) factors in different cell types that influence the myogenic functions of Pax-3. went on to show that forced expression of Pax-3 was sufficient to induce expression of myogenic bHLH genes
The finding that retroviral-mediated expression of Pax-3 can induce myogenesis in dissociated neural tube and muscle differentiation markers in cultured paraxial mesoderm and to a lesser extent in dermal fibroblasts. cells, even though these cells normally express Pax-3, suggests that elevating Pax-3 expression above a Lateral mesoderm, which normally acts as a source of signals that inhibit myogenesis, was also induced to threshold can trigger the myogenic program. The interpretation favored by Maroto et al. (1997) is that the express MyoD and downstream markers of myogenesis in response to ectopic Pax-3 expression. Perhaps most myogenic functions of Pax-3 are normally suppressed by an inhibitor in the neural tube and that exceeding the surprising was the finding that muscle gene expression could be induced by forced expression of Pax-3 in dissoinhibitory activity of this factor with excess Pax-3 can result in myogenesis. This model assumes that potential ciated neural tube cells. These experiments were only performed in vitro; it remains to be determined whether cofactors required by Pax-3 to initiate myogenesis are expressed in the neural tube. Potential inhibitors of high levels of Pax-3 can also induce myogenesis in neural tube cells in the embryo. Whether the endogenous Pax-3 activity in the neural tube would presumably also Wnts and Shh produced by the neural tube and notochord, respectively, cooperate to induce Myf-5 and Pax-3 expression in the somites. Surface ectoderm also induces Myf-5 and MyoD expression. Myf-5 appears to regulate the early expression and Pax-3 the late expression of MyoD. Pax-3 also regulates c-Met expression, which is required for migration of muscle precursor cells to the limb bud. Myogenin acts downstream of MyoD and Myf-5 and is an essential activator of myogenesis in lateral and medial muscle lineages.
